Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022
by from Morbidity and Mortality Weekly Report (MMWR) on (#663NS)
This report describes the vaccine effectiveness of an updated (bivalent) booster dose in people who have completed their primary series.